DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Statistics

Total Valuation

DOD Biotech PCL has a market cap or net worth of THB 738.68 million. The enterprise value is 748.51 million.

Market Cap	738.68M
Enterprise Value	748.51M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	Mar 13, 2026

Share Statistics

DOD Biotech PCL has 450.41 million shares outstanding. The number of shares has decreased by -0.55% in one year.

Current Share Class	450.41M
Shares Outstanding	450.41M
Shares Change (YoY)	-0.55%
Shares Change (QoQ)	-0.89%
Owned by Insiders (%)	12.77%
Owned by Institutions (%)	19.52%
Float	348.79M

Valuation Ratios

The trailing PE ratio is 60.49.

PE Ratio	60.49
Forward PE	n/a
PS Ratio	1.29
PB Ratio	0.79
P/TBV Ratio	0.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.14, with an EV/FCF ratio of -7.25.

EV / Earnings	71.23
EV / Sales	1.31
EV / EBITDA	18.14
EV / EBIT	n/a
EV / FCF	-7.25

Financial Position

The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.07.

Current Ratio	3.28
Quick Ratio	1.26
Debt / Equity	0.07
Debt / EBITDA	1.62
Debt / FCF	-0.65
Interest Coverage	-0.41

Financial Efficiency

Return on equity (ROE) is 1.38% and return on invested capital (ROIC) is -0.16%.

Return on Equity (ROE)	1.38%
Return on Assets (ROA)	-0.08%
Return on Invested Capital (ROIC)	-0.16%
Return on Capital Employed (ROCE)	-0.13%
Weighted Average Cost of Capital (WACC)	8.17%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.51
Inventory Turnover	3.87

Taxes

Income Tax	-10.55M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.29% in the last 52 weeks. The beta is 0.78, so DOD Biotech PCL's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-6.29%
50-Day Moving Average	1.70
200-Day Moving Average	1.74
Relative Strength Index (RSI)	44.68
Average Volume (20 Days)	440,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DOD Biotech PCL had revenue of THB 570.53 million and earned 10.51 million in profits. Earnings per share was 0.02.

Revenue	570.53M
Gross Profit	190.22M
Operating Income	-1.35M
Pretax Income	2.28M
Net Income	10.51M
EBITDA	40.44M
EBIT	-1.35M
Earnings Per Share (EPS)	0.02

Balance Sheet

The company has 52.64 million in cash and 66.94 million in debt, with a net cash position of -14.30 million or -0.03 per share.

Cash & Cash Equivalents	52.64M
Total Debt	66.94M
Net Cash	-14.30M
Net Cash Per Share	-0.03
Equity (Book Value)	935.02M
Book Value Per Share	2.09
Working Capital	268.08M

Cash Flow

In the last 12 months, operating cash flow was -9.30 million and capital expenditures -94.01 million, giving a free cash flow of -103.31 million.

Operating Cash Flow	-9.30M
Capital Expenditures	-94.01M
Depreciation & Amortization	41.79M
Net Borrowing	21.88M
Free Cash Flow	-103.31M
FCF Per Share	-0.23

Margins

Gross margin is 33.34%, with operating and profit margins of -0.24% and 1.84%.

Gross Margin	33.34%
Operating Margin	-0.24%
Pretax Margin	0.40%
Profit Margin	1.84%
EBITDA Margin	7.09%
EBIT Margin	-0.24%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 3.05%.

Dividend Per Share	0.05
Dividend Yield	3.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	213.47%
Buyback Yield	0.55%
Shareholder Yield	3.57%
Earnings Yield	1.42%
FCF Yield	-13.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2